Product Information
ESCITALOPRAM OXALATE 5 MG/5 ML is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1426 per ML under NDC 16571076924. Its NADAC has been published 223 times since Jun 29, 2022.
FDA first approved this application on Apr 2, 2012. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
16571076924
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA079062FDA Approved
4/2/2012
TE Code
AA
On Market Since
4/3/2012
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM OXALATE 5 MG/5 ML has been published 223 times since Jun 29, 2022, and over the history we have for it it has declined 63.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1426 per ML |
|---|---|
| All-time high | $0.3916 (Jul 13, 2022) |
| All-time low | $0.1182 (Jul 17, 2024) |
| 52-week high | $0.1969 |
| 52-week low | $0.1190 |
| Median price | $0.1813 |
| Average price | $0.2049 |
| Largest weekly change | +81.1% (Nov 22, 2023) |
| Weeks tracked | 223 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Escitalopram Oxalate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM OXALATE 5 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM OXALATE 5 MG/5 ML, manufactured by Rising Pharma Holdings Inc., is $0.1426 per ML (NDC 16571076924), effective Sep 30, 2026.
How has the price of ESCITALOPRAM OXALATE 5 MG/5 ML changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM OXALATE 5 MG/5 ML has declined 63.6%. It has been tracked across 223 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM OXALATE 5 MG/5 ML?
Since Jun 29, 2022, the NADAC for ESCITALOPRAM OXALATE 5 MG/5 ML has ranged from a low of $0.1182 (Jul 17, 2024) to a high of $0.3916 (Jul 13, 2022), with a median of $0.1813 per ML.
Are there cheaper alternatives to ESCITALOPRAM OXALATE 5 MG/5 ML?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ESCITALOPRAM OXALATE 5 MG/5 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures ESCITALOPRAM OXALATE 5 MG/5 ML?
ESCITALOPRAM OXALATE 5 MG/5 ML (NDC 16571076924) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.